The HairMax LaserComb was designed in Australia in the late 1990s. The developmental goal for the device was to provide laser therapy for hair loss and thinning hair for users in the convenience of their own home. Before its introduction, Laser Therapy was commonly delivered using large devices called Laser Hoods that utilized very large arrays of lasers. These devices limited users seeking laser hair treatments to visit a doctor’s office or laser clinic.
By promoting an increase in cell proliferation within the hair matrix, a new anagen phase is initiated. This new anagen phase causes premature shedding of Catagen and Telogen hairs. These hairs are subsequently replaced by a healthier, thicker new anagen hair.
The HairMax LaserComb is the first and only medical device to achieve FDA Clearance for men with certain classes of male pattern baldness. The HairMax LaserComb received FDA Clearance in January 2007. A formal announcement of the clearance was made on CNBC’s “The Big Idea with Donny Deutsch” by the company’s COO. Studies have been completed on the use of the HairMax LaserComb in females and an FDA filing will occur shortly to gain clearance to market the device for females with androgenetic alopecia.
Following the FDA clearance of the HairMax LaserComb, the device gained international prominence and was featured on television and in print publications around the world.
HairMax LaserComb® Laser Phototherapy Device in the Treatment of Male Androgenetic Alopecia: A Randomized, Double-Blind, Sham Device-Controlled, Multicentre Trial
May 01, 2009; Abstract Background and objective: The use of low levels of visible or near infrared light for reducing pain, inflammation and...
HairMax Achieves New Milestones in Hair Growth with Statistically Significant Clinical Studies and FDA Clearance.(Clinical report)
May 02, 2011; Lexington International, LLC is pleased to announce that it has successfully completed 2 clinical studies of the HairMax...